| PERIOD ENDING |
22-Nov-09 |
30-Aug-09 |
10-May-09 |
15-Feb-09 |
| Total Revenue |
17,299,000 |
22,378,000 |
15,806,000 |
16,843,000 |
| Cost of Revenue |
15,081,000 |
19,512,000 |
13,776,000 |
14,771,000 |
|
| Gross Profit |
2,218,000 |
2,866,000 |
2,030,000 |
2,072,000 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative |
1,779,000 |
2,254,000 |
1,655,000 |
1,666,000 |
| Non Recurring |
11,000 |
14,000 |
16,000 |
8,000 |
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss |
428,000 |
598,000 |
359,000 |
398,000 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
18,000 |
15,000 |
16,000 |
(4,000) |
| Earnings Before Interest And Taxes |
446,000 |
613,000 |
363,000 |
406,000 |
| Interest Expense |
24,000 |
33,000 |
25,000 |
25,000 |
| Income Before Tax |
422,000 |
580,000 |
338,000 |
381,000 |
| Income Tax Expense |
152,000 |
206,000 |
128,000 |
142,000 |
| Minority Interest |
(4,000) |
-
|
2,000 |
(2,000) |
| |
| Net Income From Continuing Ops |
266,000 |
374,000 |
210,000 |
239,000 |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
266,000 |
374,000 |
210,000 |
239,000 |
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
|
|
| Net Income Applicable To Common Shares |
$266,000 |
$374,000 |
$210,000 |
$239,000 |
|